Cost-Effectiveness Analysis of Antithyroid Drug Therapy, 131I Therapy and Subtotal Thyroidectomy for Graves' Disease

The objective of this study was to assess the cost-effectiveness of antithyroid drug (ATD) therapy vs. radioiodine therapy (RIT) vs. subtotal thyroidectomy (STT) by calculating expected lifelong cost and utility based on Graves' disease patients' responses to questionnaires using a decisio...

Full description

Saved in:
Bibliographic Details
Published inRADIOISOTOPES Vol. 56; no. 2; pp. 65 - 76
Main Authors YAMAMOTO, Masayoshi, KOSUDA, Shigeru, HAYASHI, Katsumi, WATANABE, Sadahiro, TANAKA, Yuji, KITA, Tamotsu, YANG, Fuzuki
Format Journal Article
LanguageEnglish
Published Japan Radioisotope Association 15.02.2007
Subjects
Online AccessGet full text
ISSN0033-8303
1884-4111
1884-4111
DOI10.3769/radioisotopes.56.65

Cover

More Information
Summary:The objective of this study was to assess the cost-effectiveness of antithyroid drug (ATD) therapy vs. radioiodine therapy (RIT) vs. subtotal thyroidectomy (STT) by calculating expected lifelong cost and utility based on Graves' disease patients' responses to questionnaires using a decision-tree sensitivity analysis and relevant variables. The decision-tree sensitivity analysis to determine expected lifelong cost and utility in Graves' disease patients was designed on the basis of the 4 competing strategies consisting of: (1) ATD therapy plus RIT strategy, (2) ATD therapy plus STT strategy, (3) low-fixed-dose (185 MBq) RIT alone strategy, and (4) high-fixed-dose (370 MBq) RIT alone strategy. One-way sensitivity analysis was designed in the ATD therapy plus RIT strategy, for replacement with RIT in place of ATD, ranging from a 100 incidence of ATD side effects to 30%. The low-fixed-dose RIT alone strategy was least costly, and the high-fixed-dose RIT alone strategy most costly. The lifelong utility of high-fixed-dose RIT alone strategy with a 5% rate of discounting was highest (lifelong utility for 30 years : 15.2/patient), and the utility of the ATD plus RIT strategy with 100 side effects of the ATD was lowest (14.1/patient) . The cost-effectiveness ratio was lowest (\5 008/utility) in a low-fixed-dose RIT alone strategy. In conclusion, a low-fixed-dose RIT alone strategy is preferred treatments in view of cost-effectiveness ratio, and RIT should be used more widely in Japan.
ISSN:0033-8303
1884-4111
1884-4111
DOI:10.3769/radioisotopes.56.65